Loading...
Immunotherapy coming of age: What will it take to make it standard of care for glioblastoma?
With the recent approval by the FDA of an immunotherapy for prostate cancer and another positive immunotherapy trial in melanoma, immunotherapy may finally be coming of age. So what will it take for it to become part of the standard treatment for glioblastoma? To put this question into perspective,...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Oxford University Press
2011
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3018912/ https://ncbi.nlm.nih.gov/pubmed/21149252 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noq169 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|